Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EC Approves Opdivo for Previously Treated Locally Advanced Unresectable or Metastatic Urothelial Car

americanpharmaceuticalreviewJune 07, 2017

Tag: Opdivo , Bladder cancer , metastatic urothelial carcinoma

PharmaSources Customer Service